Fernando Lopitz Otsoa joined CIC bioGUNE in 2006. He obtained his PhD in 2004 from the University of the Basque Country (UPV/EHU) funded by this same institution. During this period, his research was focused on antibiotic resistance mechanisms. During those years he developed part of his Thesis work at the Department of Microbiology & Public Health Laboratory at Queen's Medical Centre in Nottingham (UK). After this period, his post-doctoral studies involved molecular method and reagent development for the detection of foodborne pathogens at the Faculty of Pharmacy at the UPV/EHU and afterwards his research interests led him to work on post-translational modifications and more precisely ubiquitination, sumoylation and needylation (2006-2012) in the Proteomics Unit of CIC bioGUNE (2006-2012) and Liver Disease/Liver Metabolism Lab (2012-2019). At present, he is part of the permanent staff of CIC bioGUNE (Research Assistant) in the Precision Medicine and Metabolism Laboratory. He has coauthored more than 30 papers in the last 10 years and has reviewed for several journals of his research area.